David J. Spiegelhalter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
David J. Spiegelhalter has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Nicky Best
Imperial College London , UK
2 shared publications Nicola G. Best
Imperial College School of Medicine , London , UK
2 shared publications- Andrew Thomas
School of Mathematics and Statistics, University of St Andrews, St Andrews, U.K.
1 shared publication - Andrew Toby Prevost
King's College London London UK
1 shared publication Angelika Van Der Linde
University of Bremen , Germany
1 shared publication- Ann Louise Kinmonth
University of Cambridge Department of Public Health and Primary Care, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK
1 shared publication
Latest Publications
- 12 April 2013
- Published by SAGE Publications
- p. 275-294
Bayesian Methods
- 13 October 2009
- Published by Wiley in Statistics in Medicine
- Vol. 28 (25) , 3081-3082
Rejoinder to commentaries on ‘The BUGS project: Evolution, critique and future directions’
- 13 October 2009
- Published by Wiley in Statistics in Medicine
- Vol. 28 (25) , 3081-3082
Rejoinder to commentaries on ‘The BUGS project: Evolution, critique and future directions’
- 1 April 2006
- Published by Taylor & Francis in Journal of Quality Technology
- Vol. 38 (2) , 124-126
Discussion
(2006). Discussion. Journal of Quality Technology: Vol. 38, No. 2, pp. 124-126.
- 1 April 2006
- Published by Taylor & Francis in Journal of Quality Technology
- Vol. 38 (2) , 124-126
Discussion
(2006). Discussion. Journal of Quality Technology: Vol. 38, No. 2, pp. 124-126.
- 1 March 2006
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 33 (2) , 217-232
Strategies for inference robustness in focused modelling
Advances in computation mean that it is now possible to fit a wide range of complex models to data, but there remains the problem of selecting a model on which to base reported inferences. Following an early suggestion of Box & Tiao, it seems reasonable to seek ‘inference robustness’ in reported models, so that alternative assumptions that are reasonably well supported would not lead to substantially different conclusions. We propose a four-stage modelling strategy in which we iteratively assess and elaborate an initial model, measure the support for each of the resulting family of models, assess the influence of adopting alternative models on the conclusions of primary interest, and identify whether an approximate model can be reported. The influence-support plot is then introduced as a tool to aid model comparison. The strategy is semi-formal, in that it could be embedded in a decision-theoretic framework but requires substantive input for any specific application. The one restriction of the strategy is that the quantity of interest, or ‘focus’, must retain its interpretation across all candidate models. It is, therefore, applicable to analyses whose goal is prediction, or where a set of common model parameters are of interest and candidate models make alternative distributional assumptions. The ideas are illustrated by two examples. Technical issues include the calibration of the Kullback–Leibler divergence between marginal distributions, and the use of alternative measures of support for the range of models fitted.
- 1 March 2006
- Published by Taylor & Francis in Journal of Applied Statistics
- Vol. 33 (2) , 217-232
Strategies for inference robustness in focused modelling
Advances in computation mean that it is now possible to fit a wide range of complex models to data, but there remains the problem of selecting a model on which to base reported inferences. Following an early suggestion of Box & Tiao, it seems reasonable to seek ‘inference robustness’ in reported models, so that alternative assumptions that are reasonably well supported would not lead to substantially different conclusions. We propose a four-stage modelling strategy in which we iteratively assess and elaborate an initial model, measure the support for each of the resulting family of models, assess the influence of adopting alternative models on the conclusions of primary interest, and identify whether an approximate model can be reported. The influence-support plot is then introduced as a tool to aid model comparison. The strategy is semi-formal, in that it could be embedded in a decision-theoretic framework but requires substantive input for any specific application. The one restriction of the strategy is that the quantity of interest, or ‘focus’, must retain its interpretation across all candidate models. It is, therefore, applicable to analyses whose goal is prediction, or where a set of common model parameters are of interest and candidate models make alternative distributional assumptions. The ideas are illustrated by two examples. Technical issues include the calibration of the Kullback–Leibler divergence between marginal distributions, and the use of alternative measures of support for the range of models fitted.
Problems in assessing rates of infection with methicillin resistant Staphylococcus aureus
One of the core standards set by the Department of Health is to achieve year on year reductions in rates of infection with methicillin resistant Staphylococcus aureus (MRSA).1 This was clarified in November 2004 by the (then) health secretary John Reid, who said that he expected “MRSA bloodstream infection rates to be halved in our hospitals by 2008,” that “NHS Acute Trusts will be tasked with achieving a year on year reduction,”2 and that such a target was “achievable, measurable, and not too burdensome.” Several problems can arise, however, when measuring change in rates, particularly when the observed number of events is fairly low. These include the effects of chance variability, regression to the mean, and low power to detect genuine underlying changes. These problems are accentuated with an infectious disease, since cases tend to cluster and hence rates are “over-dispersed” relative to chance variation.3 So how should we interpret government targets on MRSA infections?
Problems in assessing rates of infection with methicillin resistant Staphylococcus aureus
One of the core standards set by the Department of Health is to achieve year on year reductions in rates of infection with methicillin resistant Staphylococcus aureus (MRSA).1 This was clarified in November 2004 by the (then) health secretary John Reid, who said that he expected “MRSA bloodstream infection rates to be halved in our hospitals by 2008,” that “NHS Acute Trusts will be tasked with achieving a year on year reduction,”2 and that such a target was “achievable, measurable, and not too burdensome.” Several problems can arise, however, when measuring change in rates, particularly when the observed number of events is fairly low. These include the effects of chance variability, regression to the mean, and low power to detect genuine underlying changes. These problems are accentuated with an infectious disease, since cases tend to cluster and hence rates are “over-dispersed” relative to chance variation.3 So how should we interpret government targets on MRSA infections?
- Open Access
- 1 October 2005
- Published by BMJ in Quality and Safety in Health Care
- Vol. 14 (5) , 347-351
Handling over-dispersion of performance indicators
Objectives: A problem can arise when a performance indicator shows substantially more variability than would be expected by chance alone, since ignoring such “over-dispersion” could lead to a large number of institutions being inappropriately classified as “abnormal”. A number of options for handling this phenomenon are investigated, ranging from improved risk stratification to fitting a statistical model that robustly estimates the degree of over-dispersion. Design: Retrospective analysis of publicly available data on survival following coronary artery bypass grafts, emergency readmission rates, and teenage pregnancies. Setting: NHS trusts in England. Results: Funnel plots clearly show the influence of the method chosen for dealing with over-dispersion on the “banding” a trust receives. Both multiplicative and additive approaches are feasible and give intuitively reasonable results, but the additive random effects formulation appears to have a stronger conceptual foundation. Conclusion: A random effects model may offer a reasonable solution. This method has now been adopted by the UK Healthcare Commission in their derivation of star ratings.
- 1 October 2005
- Published by BMJ in Quality and Safety in Health Care
- Vol. 14 (5) , 347-351
Open AccessHandling over-dispersion of performance indicators
Objectives: A problem can arise when a performance indicator shows substantially more variability than would be expected by chance alone, since ignoring such “over-dispersion” could lead to a large number of institutions being inappropriately classified as “abnormal”. A number of options for handling this phenomenon are investigated, ranging from improved risk stratification to fitting a statistical model that robustly estimates the degree of over-dispersion. Design: Retrospective analysis of publicly available data on survival following coronary artery bypass grafts, emergency readmission rates, and teenage pregnancies. Setting: NHS trusts in England. Results: Funnel plots clearly show the influence of the method chosen for dealing with over-dispersion on the “banding” a trust receives. Both multiplicative and additive approaches are feasible and give intuitively reasonable results, but the additive random effects formulation appears to have a stronger conceptual foundation. Conclusion: A random effects model may offer a reasonable solution. This method has now been adopted by the UK Healthcare Commission in their derivation of star ratings.
- 29 November 2004
- Published by Wiley in Statistics in Medicine
- Vol. 24 (8) , 1185-1202
Funnel plots for comparing institutional performance
‘Funnel plots’ are recommended as a graphical aid for institutional comparisons, in which an estimate of an underlying quantity is plotted against an interpretable measure of its precision. ‘Control limits’ form a funnel around the target outcome, in a close analogy to standard Shewhart control charts. Examples are given for comparing proportions and changes in rates, assessing association between outcome and volume of cases, and dealing with over‐dispersion due to unmeasured risk factors. We conclude that funnel plots are flexible, attractively simple, and avoid spurious ranking of institutions into ‘league tables’. Copyright © 2004 John Wiley & Sons, Ltd.
- 29 November 2004
- Published by Wiley in Statistics in Medicine
- Vol. 24 (8) , 1185-1202
Funnel plots for comparing institutional performance
‘Funnel plots’ are recommended as a graphical aid for institutional comparisons, in which an estimate of an underlying quantity is plotted against an interpretable measure of its precision. ‘Control limits’ form a funnel around the target outcome, in a close analogy to standard Shewhart control charts. Examples are given for comparing proportions and changes in rates, assessing association between outcome and volume of cases, and dealing with over‐dispersion due to unmeasured risk factors. We conclude that funnel plots are flexible, attractively simple, and avoid spurious ranking of institutions into ‘league tables’. Copyright © 2004 John Wiley & Sons, Ltd.
- Open Access
- 18 October 2004
- Published by Springer Nature in BMC Public Health
- Vol. 4 (1) , 1-12
The ProActivetrial protocol – a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766]
Background: Increasing prevalence of obesity and disorders associated with sedentary living constitute a major global public health problem. While previous evaluations of interventions to increase physical activity have involved communities or individuals with established disease, less attention has been given to interventions for individuals at risk of disease. Methods/design: ProActiveaims to evaluate the efficacy of a theoretical, evidence- and family-based intervention programme to increase physical activity in a sedentary population, defined as being at-risk through having a parental family history of diabetes. Primary care diabetes or family history registers were used to recruit 365 individuals aged 30–50 years, screened for activity level. Participants were assigned by central randomisation to three intervention programmes: brief written advice (comparison group), or a psychologically based behavioural change programme, delivered either by telephone (distance group) or face-to-face in the family home over one year. The protocol-driven intervention programme is delivered by trained facilitators, and aims to support increases in physical activity through the introduction and facilitation of a range of self-regulatory skills (e.g. goal setting). The primary outcome is daytime energy expenditure and its ratio to resting energy expenditure, measured at baseline and one year using individually calibrated heart rate monitoring. Secondary measures include self-report of individual and family activity, psychological mediators of behaviour change, physiological and biochemical correlates, acceptability, and costs, measured at baseline, six months and one year. The primary intention to treat analysis will compare groups at one-year post randomisation. Estimation of the impact on diabetes incidence will be modelled using data from a parallel ten-year cohort study using similar measures. Discussion: ProActiveis the first efficacy trial of an intervention programme to promote physical activity in a defined high-risk group accessible through primary care. The intervention programme is based on psychological theory and evidence; it introduces and facilitates the use of self-regulatory skills to support behaviour change and maintenance. The trial addresses a range of methodological weaknesses in the field by careful specification and quality assurance of the intervention programme, precise characterisation of participants, year-long follow-up and objective measurement of physical activity. Due to report in 2005, ProActivewill provide estimates of the extent to which this approach could assist at-risk groups who could benefit from changes in behaviours affecting health, and inform future pragmatic trials.
- 18 October 2004
- Published by Springer Nature in BMC Public Health
- Vol. 4 (1) , 1-12
Open AccessThe ProActivetrial protocol – a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766]
Background: Increasing prevalence of obesity and disorders associated with sedentary living constitute a major global public health problem. While previous evaluations of interventions to increase physical activity have involved communities or individuals with established disease, less attention has been given to interventions for individuals at risk of disease. Methods/design: ProActiveaims to evaluate the efficacy of a theoretical, evidence- and family-based intervention programme to increase physical activity in a sedentary population, defined as being at-risk through having a parental family history of diabetes. Primary care diabetes or family history registers were used to recruit 365 individuals aged 30–50 years, screened for activity level. Participants were assigned by central randomisation to three intervention programmes: brief written advice (comparison group), or a psychologically based behavioural change programme, delivered either by telephone (distance group) or face-to-face in the family home over one year. The protocol-driven intervention programme is delivered by trained facilitators, and aims to support increases in physical activity through the introduction and facilitation of a range of self-regulatory skills (e.g. goal setting). The primary outcome is daytime energy expenditure and its ratio to resting energy expenditure, measured at baseline and one year using individually calibrated heart rate monitoring. Secondary measures include self-report of individual and family activity, psychological mediators of behaviour change, physiological and biochemical correlates, acceptability, and costs, measured at baseline, six months and one year. The primary intention to treat analysis will compare groups at one-year post randomisation. Estimation of the impact on diabetes incidence will be modelled using data from a parallel ten-year cohort study using similar measures. Discussion: ProActiveis the first efficacy trial of an intervention programme to promote physical activity in a defined high-risk group accessible through primary care. The intervention programme is based on psychological theory and evidence; it introduces and facilitates the use of self-regulatory skills to support behaviour change and maintenance. The trial addresses a range of methodological weaknesses in the field by careful specification and quality assurance of the intervention programme, precise characterisation of participants, year-long follow-up and objective measurement of physical activity. Due to report in 2005, ProActivewill provide estimates of the extent to which this approach could assist at-risk groups who could benefit from changes in behaviours affecting health, and inform future pragmatic trials.
- 14 November 2003
- Published by Wiley in Statistics in Medicine
- Vol. 22 (23) , 3687-3709
Bayesian approaches to multiple sources of evidence and uncertainty in complex cost‐effectiveness modelling
Increasingly complex models are being used to evaluate the cost‐effectiveness of medical interventions. We describe the multiple sources of uncertainty that are relevant to such models, and their relation to either probabilistic or deterministic sensitivity analysis. A Bayesian approach appears natural in this context. We explore how sensitivity analysis to patient heterogeneity and parameter uncertainty can be simultaneously investigated, and illustrate the necessary computation when expected costs and benefits can be calculated in closed form, such as in discrete‐time discrete‐state Markov models. Information about parameters can either be expressed as a prior distribution, or derived as a posterior distribution given a generalized synthesis of available data in which multiple sources of evidence can be differentially weighted according to their assumed quality. The resulting joint posterior distributions on costs and benefits can then provide inferences on incremental cost‐effectiveness, best presented as posterior distributions over net‐benefit and cost‐effectiveness acceptability curves. These ideas are illustrated with a detailed running example concerning the cost‐effectiveness of hip prostheses in different age–sex subgroups. All computations are carried out using freely available software for conducting Markov chain Monte Carlo analysis. Copyright 2003 John Wiley & Sons, Ltd.
- 14 November 2003
- Published by Wiley in Statistics in Medicine
- Vol. 22 (23) , 3687-3709
Bayesian approaches to multiple sources of evidence and uncertainty in complex cost‐effectiveness modelling
Increasingly complex models are being used to evaluate the cost‐effectiveness of medical interventions. We describe the multiple sources of uncertainty that are relevant to such models, and their relation to either probabilistic or deterministic sensitivity analysis. A Bayesian approach appears natural in this context. We explore how sensitivity analysis to patient heterogeneity and parameter uncertainty can be simultaneously investigated, and illustrate the necessary computation when expected costs and benefits can be calculated in closed form, such as in discrete‐time discrete‐state Markov models. Information about parameters can either be expressed as a prior distribution, or derived as a posterior distribution given a generalized synthesis of available data in which multiple sources of evidence can be differentially weighted according to their assumed quality. The resulting joint posterior distributions on costs and benefits can then provide inferences on incremental cost‐effectiveness, best presented as posterior distributions over net‐benefit and cost‐effectiveness acceptability curves. These ideas are illustrated with a detailed running example concerning the cost‐effectiveness of hip prostheses in different age–sex subgroups. All computations are carried out using freely available software for conducting Markov chain Monte Carlo analysis. Copyright 2003 John Wiley & Sons, Ltd.
- Top Cited PapersOpen Access
- 1 October 2002
- Published by Oxford University Press (OUP) in Journal of the Royal Statistical Society Series B: Statistical Methodology
- Vol. 64 (4) , 583-639
Bayesian Measures of Model Complexity and Fit
- 1 October 2002
- Published by Oxford University Press (OUP) in Journal of the Royal Statistical Society Series B: Statistical Methodology
- Vol. 64 (4) , 583-639
Top Cited PapersOpen AccessBayesian Measures of Model Complexity and Fit